Skip to main content
. 2020 Apr 22;7(4):22. doi: 10.3390/medicines7040022

Table 1.

Baseline characteristics (full analysis set population).

Intervention Arm Placebo Arm p–Value
FACTORS n = 61 n = 56
Sex
M [%] (n): F [%] (n) 57% (35): 43% (26) 48% (27): 52% (29) -
Age [mean (SD years)
M: F 61.1 (12.6): 60.8 (8.6) 63.7 (11.4): 60.1 (9.0) -
Height [mean (SD) cm] 169.6 (10.8) 168.5 (10.5) 0.55
Weight [mean (SD) kg] 90.7 (19.1) 90.0 (18.9) 0.84
BMI ≥ 25 [%] 89% (54) 95% (53) 0.68
FPG [5.5–6.9 mmol/L] [%] 66% (40) 62% (35) 0.73
FPG, mean (SD) 5.9 (0.9) mmol/L 5.9 (0.8) mmol/L 0.94
OGTT 1 h ≥ 8.6 mmol/L [%] 93% (57) 95% (53) -
1 h post OGTT mean (SD) 11.3 (2.4) mmol/L 10.7 (3.1) mmol/L 0.25
2 h post OGTT mean (SD) 8.2 (3.1) mmol/L 7.8 (3.0) mmol/L 0.49
Insulin mU/L fast mean (SD) 16.6 (8.1) 17.6 (11.4) 0.60
Insulin mU/L 1 h mean (SD) 130.0 (76.7) 130.9 (71.9) 0.95
Insulin mU/L 2 h mean (SD) 101.4 (73.8) 102.7 (71.5) 0.93
HbA1c % fast mean (SD) 5.7 (0.4) 5.6 (0.5) 0.25
With prescribed metformin
FBG mmol/L
1 h post OGTT mean (SD)
2 h post OGTT mean (SD)
7/61 (11.5%)
6.2 (0.6)
m12.9 (3.1)
10.8 (5.0)
10/56 (17.9%)
5.4 (0.5)
10.8 (3.1)
7.5 (3.4)
0.35

Notes: BMI = body mass index; FPG = fasting plasma glucose; OGTT = oral glucose tolerance test.